Clinical Trials Browser

Neoplasm, Residual × obinutuzumab × Other hematologic neoplasm × Clear all

NCT02666898 2025-11-26

ICLL07GAI

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual